Search alternatives:
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
latest decrease » largest decrease (Expand Search), greatest decrease (Expand Search), largest decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a latest » _ latest (Expand Search), a latent (Expand Search), _ latent (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
latest decrease » largest decrease (Expand Search), greatest decrease (Expand Search), largest decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a latest » _ latest (Expand Search), a latent (Expand Search), _ latent (Expand Search)
-
8741
-
8742
-
8743
-
8744
-
8745
Changes in HbA1c, FPG and 2 h PG in the Jinlida group and placebo group.
Published 2015“…<p>(A) Left: The mean HbAlc decreased significantly in both groups between the baseline and after treatment. …”
-
8746
Oleic acid (OA) leads to a significant increase in viability and migration in MCF10DCIS.COM cells compared with other breast cancer cell lines.
Published 2016“…<p>(A) Cell viability in diverse breast cancer cells incubated with 0.1 mM OA. …”
-
8747
Parametrization of the shapes of linear filter sets.
Published 2017“…(A) Individual short-term linear filters for 209 ORNs sorted by decreasing parameter <i>φ</i> (see (E)). …”
-
8748
-
8749
Linear repression using auto-regulation.
Published 2010“…<p>If in the simulations we selected for a linearly decreasing response function (a LIN gate), auto-activation emerged. …”
-
8750
A randomized controlled trial of Roux-en-Y gastrojejunostomy vs. gastroduodenostomy with respect to the improvement of type 2 diabetes mellitus after distal gastrectomy in gastric...
Published 2017“…Sixty percent of RY patients and 20% of BI patients decreased their medication satisfying FBS<126 mg/dL and HbA1c<6.5% and 5% of BI patients stopped their medication satisfying the criteria of FBS<126 mg/dL and HbA1c<6.0%. …”
-
8751
Polymorphisms and haplotypes in the promoter of the TNF-α gene are associated with disease severity of severe fever with thrombocytopenia syndrome in Chinese Han population
Published 2018“…Furthermore, T-1031C <i>C</i> allele (<i>P</i> < 0.001) and G-238A <i>A</i> allele (<i>P</i> < 0.001) were significantly associated with decreased risk of death. …”
-
8752
Changes in HOMA-IR and HOMA-β after 12 weeks treatment in the Jinlida group and placebo group.
Published 2015“…<p>(A) Left: The mean HOMA-IR decreased somewhat in both groups between the baseline and after treatment. …”
-
8753
-
8754
-
8755
-
8756
Linear relationships between model parameters.
Published 2013“…<p>Certain linear relationships between CSC self-renewal and differentiation kinetic parameters allow identification of families of feasible solutions: (A) By increasing Φ<sub>2/1</sub> while proportionally decreasing Φ<sub>4/1</sub> a family of feasible model solutions can be found. …”
-
8757
Shift toward greater pathologic post-myocardial infarction remodeling with loss of the adaptive hypertrophic signaling of alpha1 adrenergic receptors in mice
Published 2017“…</p><p>Results</p><p>Alpha1A-AR knockout paradoxically increased post-MI hypertrophy compared to wild type controls (WT), but also increased ventricular dilatation, fibrosis, apoptosis, and 4-week post-MI mortality (64% in AKO vs. 25% in WT, P = 0.02), suggesting a shift toward greater pathologic hypertrophy in the absence of pro-adaptive alpha1A effects. alpha1A-AR knockout increased phospho-p38 levels in the pre-MI myocardium compared to WT (0.55 ± 0.16 vs. 0.03 ± 0.01, P<0.05) but decreased phospho-ERK1/2 post-MI (0.49 ± 0.35 arbitrary units vs. 1.55 ± 0.43 in WT, P<0.05). …”
-
8758
-
8759
Oleic acid (OA) leads to the strong phosphorylation of FAK and AKT in ALDH<sup>high</sup> cells, resulting in high proliferation and migration.
Published 2016“…<p>(A) Representative Western blot of the phosphorylation of FAK, AKT and ERK1/2 in ALDH<sup>high</sup> cells and ALDH<sup>low</sup> cells treated with OA. …”
-
8760
Sinupret is a robust activator of CFTR-mediated and calcium-activated Cl<sup>-</sup> secretion.
Published 2014“…Sinupret significantly increased ΔI<sub>SC</sub> (in µA/cm<sup>2</sup>)when compared to controls in both WT (20.7+/−0.9 vs. 5.6+/−0.9, p<0.05) and CFTR<sup>−/−</sup> MNSE (ΔI<sub>SC</sub> in µA/cm<sup>2</sup>, 10.1+/−1.0 vs. 0.9+/−0.3, p<0.05). …”